The 9th “Dysmorphology in the Genomics Era” course, held in Manchester at the Nowgen Centre, was a resounding success. Already a leading centre for clinical genomics in Europe, MCGM demonstrated the increasingly global reach, with attendees coming from the USA, Saudi Arabia, India, Malaysia, Palestine, and Argentina. The faculty was almost all Manchester-based from the University of Manchester, and MCGM. 14 scholarships were awarded from the European Society of Human Genetics (ESHG) and the European Reference Network, ERN-Ithaca.
US-based company FDNA have awarded the Manchester Centre for Genomic Medicine a Centers of Research Excellence grant, providing funding to next-generation phenotyping (NGP) research. It will also bring FDNA’s Face2Gene facial analysis technology to the centre, ushering in a new era of precision medicine.
Led by Prof Jill Clayton-Smith, Consultant Clinical Geneticist at Saint Mary’s Hospital and Honorary Professor in Medical Genetics at The University of Manchester, and Dr Sophia Douzgou, the Manchester Centre will use FDNA’s Face2Gene suite of applications for research and clinical evaluations of patients.
Central Manchester University Hospitals NHS Foundation Trust staff marked Rare Disease Day 2017 with a number of activities within the Royal Manchester Children’s Hospital.
Staff from the clinical, laboratory and research teams within Manchester Centre For Genomic Medicine manned a stall to provide information to parents and fun activities about rare conditions ranging from making genetic code bracelets to actually being able to see and take home your own DNA.
Those participating included Professor Jill-Clayton Smith, Consultant Clinical Geneticist at CMFT, who, on Rare Disease Day was also named as the network co-ordinator for the European Reference Network (ERN) for congenital malformations and rare intellectual disability (ERN-ITHACA), to be led from CMFT.
Read more about Rare Disease Day 2017 on the CMFT website.